Evidence map›Paper›PMID 31572306›Full record

ArticleFrontiers in endocrinology2019

In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus.

Hongyan Lin, Yang Yuan, Sai Tian, Jing Han, Rong Huang, Dan Guo, Jiaqi Wang, Ke An, Shaohua Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. FNDC5/Irisin in dementia and cognitive impairment: update and novel perspective.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hongyan LinDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Yang YuanDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Sai TianDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Jing HanDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Rong HuangDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Dan GuoDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Jiaqi WangDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Ke AnDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Shaohua WangDepartment of Endocrinology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China.
Zhongda Hospital Southeast University · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetes mellitusexecutive functioninsulin resistanceirisinmild cognitive impairment

Identifiers

PMID31572306
PMCPMC6753617
OpenAlexW2970222836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.